# EFAVIRENZ
> **ANDA078064** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2017-12-15
## Drug
- **FDA Application Number:** ANDA078064
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EFAVIRENZ
- **Generic name:** EFAVIRENZ
- **Active ingredients:** EFAVIRENZ
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2017-12-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078064)
---
*MORVS · CC0 1.0*